Rheumatoid Arthritis: Current Studies, Therapeutic Options and Mechanisms of Action

Title:

Rheumatoid Arthritis: Current Studies, Therapeutic Options and Mechanisms of Action

Topic: Rheumatology
Relevant Terms: Rheumatoid arthritis DMARDs, patient management
Primary Audience: rheumatologists, rheumatology nurse practitioners, rheumatology physician assistants and other health care providers involved in the management and treatment of patients who have been diagnosed with RA.
Launch Date: 17-Mar-15
Credits: AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: RA MOA

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Describe therapeutic mechanisms of intervention for newer agents for rheumatoid arthritis
  2. Analyze recent safety and efficacy data for newer agents used to treat rheumatoid arthritis
  3. Formulate strategies to manage treatment of patients with rheumatoid arthritis who do not respond adequately to their current therapeutic regimen

    Faculty

    Gregg J. Silverman, MD
    Professor of Medicine & Pathology
    NYU School of Medicine
    New York, NY
    Joel Kremer, MD
    Pfaff Family Professor of Medicine
    Albany Medical College
    Director of Research
    The Center for Rheumatology
    Albany, NY
    Release date: March 17, 2015
    Expiration date: March 17, 2016
    Estimated time to complete activity: 1.0 hour
     
    Activity Overview
    This activity is intended to advance participant knowledge, competence and performance and to encourage changes in practice that address gaps in clinical practice relating to management of patients who experience nonresponse to first line therapy for rheumatoid arthritis. This activity presents: 1) data on current and emerging agents for the treatment of rheumatoid arthritis; 2) mechanisms of action for newer biologic and nonbiologic agents; and 3) strategies for incorporating newer agents into practice so that a wide array of patients with rheumatoid arthritis can be successfully treated.
     
    Target Audience
    This activity is intended for the education of rheumatologists, rheumatology nurse practitioners, rheumatology physician assistants and other health care providers involved in the management and treatment of patients who have been diagnosed with RA.
     
    Accreditation Statement
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and Curatio CME Institute LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
     
    Credit Designation Statement
    The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
     
    Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.

    Faculty Disclosures

    Dr. Kremer has received honoraria from and consulted for AbbVie, Amgen, Bristol-Myers Squibb, Genentech, Pfizer, and UCB.

    Dr. Silverman has received honoraria from and consulted for Lilly, Roche, Genentech, and GSIC. He has also been a speaker for Genentech and GSIC.
     
    Other Disclosures
     
    The University of Chicago Center for Continuing Medical Education
    Mahira Zec Bonomo, MBA Director, has disclosed no relevant financial relationships.

    Curatio CME LLC
    Daniel Duch, PhD, has disclosed no relevant financial relationships.
     
    Commercial Support
    Supported by educational grants from AbbVie and Genentech and by an educational donation provided by Amgen.


    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8  
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 6+ for Mac OSX 10.7 and above

    For video playback, install the latest version of Flash or Quicktime.
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above